92857 ⎘
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
PROCESSES AND COMPOUNDS
#24-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88
#32-AMINO BENZOPHENONE DERIVATIVES FOR TARGETED FERROPTOSIS INDUCTION IN CANCER THERAPY
#4Novel GLV-Phenolamide: Biosynthesis and Function in Protecting Plants from Herbivore Attack
#5CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES
#6UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE
#7ACETYLSALICYLIC ACID DERIVATIVE AND APPLICATION THEREOF
#8RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#9POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE
#10CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES
#11Inhibitors of the n-terminal domain of the androgen receptor
#12Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#13Piperlongumine-based compound and immuno regulator comprising the same
#14PROCESSES AND COMPOUNDS
#15ORTHO-PHTHALALDEHYDE CONTAINING LINKERS AND USE FOR PREPARATION OF ANTIBODY-DRUG CONJUGATE
#16Acetylsalicylic acid derivative and application thereof
#174-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#18PROSTAGLANDIN ANALOGS AND USES THEREOF
#19Compositions for the treatment of pulmonary fibrosis
#20Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy
#21Curcumin analogues as zinc chelators and their uses
#22Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#23Compounds, compositions and methods for treating oxidative DNA damage disorders
#24Sacubitril intermediate and preparation method thereof
#25Inhibitors of the N-terminal domain of the androgen receptor
#26COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS
#27Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#28Compositions for the treatment of pulmonary fibrosis
#294-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#30Curable gellant ink
#31Preparation method for tedizolid, tedizolid intermediate, and preparation method therefor
#32Method for preparing oxazolidinone intermediate
#33Neprilysin inhibitors
#34Quinone compounds for treating APE1 mediated diseases
#35Compounds and methods for the treatment of neurodegenerative diseases
#36Enamine compounds for absorbance of electromagnetic energy
#37Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#38Histone deacetylase inhibitors
#393′-substituted-abscisic acid derivatives
#40Neprilysin inhibitors
#414-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#42Compounds, Compositions and Methods for Treating Oxidative DNA Damage Disorders
#43Curcumin analogues as zinc chelators and their uses
#44Neprilysin inhibitors
#45THERAPEUTIC AGENTS FOR OCULAR HYPERTENSION
#46Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#47Compounds with (1E, 6E)-1,7-Bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#48Histone deacetylase inhibitors
#49Compounds advantageous in the treatment of central nervous system diseases and disorders
#50CARBOXYLIC ACID DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
#514-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#52Quinone compounds for treating Ape1 mediated diseases
#53Curcumin analogues as zinc chelators and their uses
#543′-substituted-abscisic acid derivatives
#55Neprilysin inhibitors
#56SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS
#57Electrical conductive polymer binder for Si alloy materials
#58Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#59Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#60Therapeutic agents for ocular hypertension
#61Neprilysin inhibitors
#62J-series prostaglandin-ethanolamides as novel therapeutics
#63Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
#64Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
#65Histone deacetylase inhibitors
#66Compounds and methods for treating leukemia
#67Triterpenoids and compositions containing the same
#68Propenoate derivatives of betulin
#69Substituted biaryl alkyl amides
#702-substituted--quinone derivatives for treatment of oxidative stress diseases
#71SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS
#72AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
#73Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
#74Haloalkylmethyleneoxyphenyl-substituted ketoenols
#75HISTONE DEACETYLASE INHIBITORS
#76COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS
#77Quinone compounds for treating Ape1 mediated diseases
#78Haloalkylmethyleneoxyphenyl-substituted ketoenols
#79Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#80Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#81Triterpenoids and compositions containing the same
#824-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#83Compounds for the treatment of metabolic disorders
#84Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#85Modulator
#86SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#87Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#882-ARYL-PROPIONAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#89DERIVATIVES OF BETULIN
#90IRE-1α inhibitors
#91Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#924-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#93Curcumin analogues as zinc chelators and their uses
#94Compounds
#95Pyrimidine carboxamide derivatives
#96Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
#97Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid
#982-substituted--quinone derivatives for treatment of oxidative stress diseases
#99SPECIFIC INHIBITORS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
#100Haloalkylmethyleneoxyphenyl-substituted ketoenols
#101Substituted aminopropionic derivatives as neprilysin inhibitors
#102DICARBONYL DERIVATIVES AND METHODS OF USE
#103Modified malonate derivatives
#104Antibiotic compound
#105Modulator
#106ACETYLENE DERIVATIVES
#107Rupestonic acid derivatives and use thereof
#1082-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
#109Histone deacetylase inhibitors
#110Process for the synthesis of agomelatine
#111CHEMICAL DERIVATIVES OF JASMONATE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
#112Ophthalmic Compositions for Treating Ocular Hypertension
#113Substituted amides
#114Hsp90 family protein inhibitors
#115TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS
#116COMPOUND
#117Inhibitors of Histone Deacetylase
#118Spiro compounds and pharmaceutical use thereof
#119Amine compound and use thereof for medical purposes
#1204-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#121Amide Compound
#122ANTITUMOR AGENT
#123Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Pge2 Release
#1242-arylpropionic acid derivatives and pharmaceutical compositions containing them
#125Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto
#126Acetylene derivatives
#127Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#128Substituted pyridyoxy amides
#129Dicarbonyl derivatives and methods of use
#130Specific inhibitors for vascular endothelial growth factor receptors
#131Modulator
#132OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#133Compounds for the treatment of metabolic disorders
#134Compounds for the treatment of metabolic disorders
#135COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#136COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#137Method for the treatment of metabolic disorders
#138COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#139COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#140Method for the treatment of metabolic disorders
#141COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#142COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#143Methods for the treatment of metabolic disorders such as diabetes
#144Palladium-catalyzed carbon-carbon bond forming reactions
#145Aniline derivatives
#146Hsp90 family protein inhibitors
#147Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
#148Matrix metalloproteinase inhibitors
#149Compounds for the treatment of metabolic disorders
#150Inhibitors of bacterial type III protein secretion systems
#151Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#152Substituted amides
#153Compound for the treatment of metabolic disorders
#154Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#155Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode
#156α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
#157Compounds for the treatment of metabolic disorders